Substituted imidazole 4-carboxamides as cholecystokinin-1...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/06 (2006.01) A61K 31/496 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01)

Patent

CA 2649927

Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.

L'invention concerne certains nouveaux imidazole 4-carboxamides substitués qui sont des ligands du récepteur de cholécystokinine humain et, en particulier, des ligands sélectifs du récepteur de cholécystokinine-1 (CCK-1R) humain. On les utilise donc pour traiter, combattre ou prévenir des maladies et des troubles qui réagissent à la modulation de CCK-1R, par exemple l'obésité et les différents types de diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted imidazole 4-carboxamides as cholecystokinin-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted imidazole 4-carboxamides as cholecystokinin-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazole 4-carboxamides as cholecystokinin-1... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1627495

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.